About
Creo Medical is a UK-based medical device company founded in 2003, originally known as MicroOncology Ltd. The company specializes in advanced energy technology for therapeutic endoscopy, focusing on minimally invasive electrosurgical devices. Its core technology platform, the CROMA Advanced Energy platform, utilizes proprietary Kamaptive Technology to support various medical applications, including resection, dissection, haemostasis, and ablation of lesions. The product portfolio includes resection and ablation devices, diagnostic tools, therapeutic devices, and hygiene applications. The flagship device, Speedboat Inject, is recognized for its innovative approach to treatment and improved patient outcomes. Creo Medical serves healthcare professionals and hospitals globally, with operations in the UK, US, and Asia-Pacific, and employs over 280 people across nine countries. The company holds more than 300 patents, showcasing its commitment to innovation in the medical field. Under CEO Craig Gulliford's leadership since 2012, Creo Medical continues to expand its international presence and enhance surgical solutions.
Technologies
Keywords
Company Information
- Employees280
- Founded2003
- Annual Revenue$5021000
- Total Funding$139043614
Location
Chepstow, Wales, United Kingdom, NP16 5UH
